Four Ugandan patients with Kaposi's sarcoma (KS) showed initial chemotherapy response but no sustained remission. All cases tested positive for human T-lymphotropic virus type II (HTLV-II) antibodies.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: